scholarly article | Q13442814 |
P356 | DOI | 10.4049/JIMMUNOL.1700127 |
P698 | PubMed publication ID | 28724580 |
P50 | author | Julie Demaret | Q57417362 |
François Mallet | Q60614082 | ||
Julien Textoris | Q37839662 | ||
Fabienne Venet | Q38545407 | ||
P2093 | author name string | Alain Lepape | |
Guillaume Monneret | |||
Benjamin J Blaise | |||
Thomas Rimmelé | |||
Christelle Rouget | |||
Thibaut Girardot | |||
Estellie Idealisoa | |||
P2860 | cites work | Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine | Q22306067 |
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) | Q26768286 | ||
Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) | Q26768292 | ||
Monitoring the immune response in sepsis: a rational approach to administration of immunoadjuvant therapies | Q26852697 | ||
Fueling immunity: insights into metabolism and lymphocyte function | Q27025284 | ||
Severe sepsis and septic shock | Q27026614 | ||
Linear models and empirical bayes methods for assessing differential expression in microarray experiments | Q27860758 | ||
Feeding an army: The metabolism of T cells in activation, anergy, and exhaustion | Q28085624 | ||
Inhibitory effect of mTOR activator MHY1485 on autophagy: suppression of lysosomal fusion | Q28482453 | ||
Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy | Q33828888 | ||
The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function | Q33838591 | ||
Leucine Metabolism in T Cell Activation: mTOR Signaling and Beyond | Q34534303 | ||
Marked elevation of human circulating CD4+CD25+ regulatory T cells in sepsis-induced immunoparalysis. | Q34535214 | ||
Intersection of mTOR and STAT signaling in immunity | Q34978661 | ||
Persistent lymphopenia after diagnosis of sepsis predicts mortality. | Q35184876 | ||
PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation | Q35311785 | ||
Programmed death-1 levels correlate with increased mortality, nosocomial infection and immune dysfunctions in septic shock patients. | Q35559497 | ||
Immunosuppression in patients who die of sepsis and multiple organ failure | Q35991015 | ||
Small molecule-induced cytosolic activation of protein kinase Akt rescues ischemia-elicited neuronal death | Q36068891 | ||
Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis | Q36427380 | ||
A prospective analysis of lymphocyte phenotype and function over the course of acute sepsis | Q36633756 | ||
Metabolic regulation of T lymphocytes | Q36711431 | ||
Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach | Q37233354 | ||
An integrated clinico-metabolomic model improves prediction of death in sepsis | Q37584419 | ||
Metabolism in T cell activation and differentiation | Q37699927 | ||
Regulation of immune responses by mTOR. | Q37963950 | ||
Failure to normalize lymphopenia following trauma is associated with increased mortality, independent of the leukocytosis pattern | Q37977528 | ||
T cell metabolic reprogramming and plasticity | Q38567424 | ||
Lactic Acidosis in Sepsis: It's Not All Anaerobic: Implications for Diagnosis and Management | Q38588390 | ||
Regulatory circuits of T cell function in cancer | Q38928127 | ||
An optimized protocol for adenosine triphosphate quantification in T lymphocytes of lymphopenic patients | Q40512617 | ||
Emerging concepts of T cell metabolism as a target of immunotherapy. | Q40745622 | ||
Broad defects in the energy metabolism of leukocytes underlie immunoparalysis in sepsis | Q40765104 | ||
Metabolic dysfunction in lymphocytes promotes postoperative morbidity. | Q41311165 | ||
STAT5 phosphorylation in T cell subsets from septic patients in response to recombinant human interleukin-7: a pilot study | Q41477931 | ||
Decreased T-cell repertoire diversity in sepsis: a preliminary study | Q43514997 | ||
IL-7 enhances the survival and maintains the size of naive T cells | Q43819910 | ||
SRV: an open-source toolbox to accelerate the recovery of metabolic biomarkers and correlations from metabolic phenotyping datasets | Q45743470 | ||
Metabolic profiling of serum samples by 1H nuclear magnetic resonance spectroscopy as a potential diagnostic approach for septic shock. | Q50741264 | ||
Statistical recoupling prior to significance testing in nuclear magnetic resonance based metabonomics. | Q51813891 | ||
Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007. | Q53089518 | ||
Forward light scatter is a simple measure of T-cell activation and proliferation but is not universally suited for doublet discrimination. | Q53238934 | ||
Early assessment of leukocyte alterations at diagnosis of septic shock. | Q54437566 | ||
Orthogonal projections to latent structures (O-PLS) | Q56435041 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | sepsis | Q183134 |
lymphocyte | Q715347 | ||
septic shock | Q1765564 | ||
P304 | page(s) | 1606-1615 | |
P577 | publication date | 2017-07-19 | |
P1433 | published in | Journal of Immunology | Q3521441 |
P1476 | title | IL-7 Restores T Lymphocyte Immunometabolic Failure in Septic Shock Patients through mTOR Activation | |
P478 | volume | 199 |
Q47310265 | Advances in the understanding and treatment of sepsis-induced immunosuppression. |
Q98177684 | CD4 T Cell Responses and the Sepsis-Induced Immunoparalysis State |
Q90523433 | Crosstalk between Dendritic Cells and Immune Modulatory Agents against Sepsis |
Q90101108 | Immunometabolism: Another Road to Sepsis and Its Therapeutic Targeting |
Q50532589 | Interleukin-7 Unveils Pathogen-Specific T Cells by Enhancing Antigen-Recall Responses. |
Q52668621 | Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial. |
Q48101233 | Intra-cellular lactate concentration in T lymphocytes from septic shock patients - a pilot study |
Q92232738 | Intracellular calcium signaling and phospho-antigen measurements reveal functional proximal TCR activation in lymphocytes from septic shock patients |
Q92617569 | Microbial Exposure Enhances Immunity to Pathogens Recognized by TLR2 but Increases Susceptibility to Cytokine Storm through TLR4 Sensitization |
Q92538820 | NK Cell Metabolism and TGFβ - Implications for Immunotherapy |
Q58091387 | Polymicrobial sepsis influences NK-cell-mediated immunity by diminishing NK-cell-intrinsic receptor-mediated effector responses to viral ligands or infections |
Q55261444 | Polymorphism rs1385129 Within Glut1 Gene SLC2A1 Is Linked to Poor CD4+ T Cell Recovery in Antiretroviral-Treated HIV+ Individuals. |
Q92358207 | Publication Trends of Research on Sepsis and Host Immune Response during 1999-2019: A 20-year Bibliometric Analysis |
Q49790787 | Sepsis-Induced T Cell Immunoparalysis: The Ins and Outs of Impaired T Cell Immunity. |
Q58742374 | Sirtuins and Immuno-Metabolism of Sepsis |
Q64104710 | TCR activation mimics CD127PD-1 phenotype and functional alterations of T lymphocytes from septic shock patients |
Q61631793 | The Circadian Clock Controls Immune Checkpoint Pathway in Sepsis |
Q102211016 | Title NMR-based metabolic profiling provides diagnostic and prognostic information in critically ill children with suspected infection |
Q92703579 | mTOR-Dependent Stimulation of IL20RA Orchestrates Immune Cell Trafficking through Lymphatic Endothelium in Patients with Crohn's Disease |
Search more.